Glutamic Acid Decarboxylase 65 Antibodies (GAD65-Ab)
GAD65-Ab measures antibodies against the enzyme glutamic acid decarboxylase 65, which is crucial for the synthesis of the neurotransmitter GABA.
GAD65-Ab is a diagnostic biomarker for autoimmune diabetes and neurological disorders.
Key facts at a glance
- Units
- IU/mL
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche GAD Ab, Abbott GAD Ab, RSR GAD65 Ab
Glutamic acid decarboxylase 65 (GAD65) is an enzyme found in pancreatic beta cells and neurons, responsible for the synthesis of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system.
The presence of GAD65 antibodies (GAD65-Ab) in the blood indicates an autoimmune response, often associated with Type 1 diabetes and other autoimmune conditions such as stiff-person syndrome and cerebellar ataxia.
Measuring GAD65-Ab levels is essential for the early diagnosis and differentiation of these conditions, as well as for predicting the risk of developing autoimmune diabetes.
Frequently asked questions
What is the normal range for GAD65-Ab?
What conditions are associated with elevated GAD65-Ab levels?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy